Biogen IncNASDAQ:BIIB
- LAST PRICE228.7200
- TODAY'S CHANGE (%)4.2600 (1.8979%)
- Bid / Lots228.7200/ 3
- Ask / Lots230.9800/ 1
- Open / Previous Close223.4300 / 224.4600
- Day Range
- 52 Week Range
- Volume1,005,464
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BIIB |
|---|---|---|
| 09:32 ET | 5860 | 224.275 |
| 09:36 ET | 1000 | 223.1 |
| 09:38 ET | 3400 | 223.82 |
| 09:39 ET | 500 | 224.04 |
| 09:41 ET | 3700 | 224.6 |
| 09:43 ET | 2795 | 224.715 |
| 09:45 ET | 1500 | 225.2133 |
| 09:48 ET | 1955 | 225.02 |
| 09:50 ET | 1063 | 225 |
| 09:52 ET | 1064 | 225.09 |
| 09:54 ET | 2300 | 225.3 |
| 09:56 ET | 1005 | 225.6362 |
| 09:57 ET | 1310 | 225.8 |
| 09:59 ET | 1122 | 226.14 |
| 10:01 ET | 937 | 226.12 |
| 10:03 ET | 239 | 226.215 |
| 10:06 ET | 691 | 226.12 |
| 10:08 ET | 1308 | 226.0347 |
| 10:10 ET | 100 | 226.27 |
| 10:12 ET | 801 | 226.59 |
| 10:14 ET | 400 | 226.515 |
| 10:15 ET | 252 | 226.6 |
| 10:17 ET | 878 | 226.75 |
| 10:19 ET | 1519 | 227.04 |
| 10:21 ET | 3285 | 227.65 |
| 10:24 ET | 708 | 227.83 |
| 10:26 ET | 3172 | 227.695 |
| 10:28 ET | 2568 | 227.82 |
| 10:30 ET | 1326 | 227.935 |
| 10:32 ET | 300 | 228.24 |
| 10:33 ET | 1146 | 228.85 |
| 10:35 ET | 776 | 229.22 |
| 10:37 ET | 3525 | 228.62 |
| 10:39 ET | 318 | 228.82 |
| 10:42 ET | 714 | 228.83 |
| 10:44 ET | 1009 | 228.67 |
| 10:46 ET | 1627 | 229.395 |
| 10:48 ET | 4190 | 229.4 |
| 10:50 ET | 500 | 229.43 |
| 10:51 ET | 1332 | 229.255 |
| 10:53 ET | 300 | 229.54 |
| 10:55 ET | 2274 | 229.695 |
| 10:57 ET | 4361 | 229.57 |
| 11:00 ET | 800 | 229.75 |
| 11:02 ET | 2060 | 229.5 |
| 11:04 ET | 2360 | 229.2 |
| 11:06 ET | 1328 | 229.77 |
| 11:08 ET | 1912 | 229.5186 |
| 11:09 ET | 800 | 229.3 |
| 11:11 ET | 1300 | 229.08 |
| 11:13 ET | 581 | 229.19 |
| 11:15 ET | 1250 | 229.13 |
| 11:18 ET | 4653 | 229.52 |
| 11:20 ET | 1888 | 229.56 |
| 11:22 ET | 510 | 229.69 |
| 11:24 ET | 2735 | 229.54 |
| 11:26 ET | 5542 | 229.695 |
| 11:27 ET | 4365 | 230.08 |
| 11:29 ET | 2601 | 229.95 |
| 11:31 ET | 1210 | 230.06 |
| 11:33 ET | 4700 | 228.87 |
| 11:36 ET | 1351 | 228.67 |
| 11:38 ET | 1000 | 228.77 |
| 11:40 ET | 500 | 228.68 |
| 11:42 ET | 1121 | 228.625 |
| 11:44 ET | 2518 | 228.87 |
| 11:45 ET | 400 | 229.03 |
| 11:47 ET | 2300 | 228.65 |
| 11:49 ET | 150 | 228.735 |
| 11:51 ET | 507 | 228.825 |
| 11:54 ET | 3878 | 228.24 |
| 11:56 ET | 300 | 228.145 |
| 11:58 ET | 1200 | 228.33 |
| 12:00 ET | 800 | 228.1 |
| 12:02 ET | 100 | 228.1 |
| 12:03 ET | 3105 | 228.255 |
| 12:07 ET | 432 | 228.35 |
| 12:09 ET | 300 | 228.3309 |
| 12:12 ET | 381 | 228.49 |
| 12:14 ET | 1100 | 228.28 |
| 12:16 ET | 216 | 228.24 |
| 12:18 ET | 1144 | 228.19 |
| 12:20 ET | 1289 | 228.135 |
| 12:21 ET | 300 | 228.29 |
| 12:23 ET | 600 | 228.335 |
| 12:25 ET | 900 | 228.16 |
| 12:30 ET | 850 | 228.02 |
| 12:32 ET | 720 | 228.0262 |
| 12:34 ET | 700 | 227.765 |
| 12:36 ET | 5124 | 228.1308 |
| 12:38 ET | 200 | 228.14 |
| 12:39 ET | 2831 | 227.87 |
| 12:41 ET | 2212 | 227.7 |
| 12:43 ET | 1764 | 227.89 |
| 12:45 ET | 482 | 227.82 |
| 12:48 ET | 355 | 228.02 |
| 12:50 ET | 800 | 228.07 |
| 12:52 ET | 2000 | 227.885 |
| 12:54 ET | 550 | 228.02 |
| 12:56 ET | 583 | 228.02 |
| 12:57 ET | 100 | 228.005 |
| 12:59 ET | 1118 | 228.065 |
| 01:01 ET | 700 | 227.9 |
| 01:03 ET | 700 | 227.975 |
| 01:06 ET | 1300 | 227.845 |
| 01:08 ET | 2074 | 227.54 |
| 01:14 ET | 1300 | 226.7914 |
| 01:15 ET | 300 | 226.775 |
| 01:17 ET | 300 | 226.75 |
| 01:19 ET | 2492 | 226.62 |
| 01:21 ET | 835 | 226.52 |
| 01:24 ET | 2746 | 227.19 |
| 01:26 ET | 200 | 227.225 |
| 01:28 ET | 300 | 227.265 |
| 01:30 ET | 300 | 227.335 |
| 01:32 ET | 300 | 227.245 |
| 01:33 ET | 1400 | 227.16 |
| 01:35 ET | 300 | 227.135 |
| 01:37 ET | 600 | 227 |
| 01:39 ET | 520 | 227.18 |
| 01:42 ET | 100 | 227.29 |
| 01:44 ET | 1300 | 227.32 |
| 01:46 ET | 700 | 227.41 |
| 01:48 ET | 829 | 227.535 |
| 01:50 ET | 200 | 227.625 |
| 01:51 ET | 1100 | 227.88 |
| 01:53 ET | 2168 | 227.86 |
| 01:55 ET | 1498 | 227.87 |
| 01:57 ET | 1600 | 227.85 |
| 02:00 ET | 100 | 227.84 |
| 02:02 ET | 5250 | 227.83 |
| 02:04 ET | 354 | 227.87 |
| 02:06 ET | 2036 | 227.94 |
| 02:08 ET | 695 | 227.99 |
| 02:09 ET | 3219 | 227.5 |
| 02:11 ET | 200 | 227.595 |
| 02:13 ET | 763 | 227.46 |
| 02:15 ET | 100 | 227.395 |
| 02:18 ET | 773 | 227.34 |
| 02:20 ET | 200 | 227.345 |
| 02:22 ET | 200 | 227.405 |
| 02:24 ET | 1174 | 227.22 |
| 02:26 ET | 278 | 227.205 |
| 02:27 ET | 200 | 227.155 |
| 02:29 ET | 650 | 227.16 |
| 02:31 ET | 1596 | 227.5 |
| 02:33 ET | 221 | 227.485 |
| 02:36 ET | 400 | 227.6 |
| 02:38 ET | 2019 | 227.98 |
| 02:40 ET | 3212 | 228.22 |
| 02:42 ET | 1764 | 228.31 |
| 02:44 ET | 2581 | 228.13 |
| 02:45 ET | 500 | 228.065 |
| 02:47 ET | 321 | 228.11 |
| 02:49 ET | 1300 | 228.055 |
| 02:51 ET | 700 | 228.005 |
| 02:54 ET | 300 | 227.99 |
| 02:56 ET | 400 | 228.005 |
| 02:58 ET | 2114 | 228 |
| 03:00 ET | 3832 | 227.97 |
| 03:02 ET | 2300 | 227.97 |
| 03:03 ET | 3125 | 227.88 |
| 03:05 ET | 3316 | 227.96 |
| 03:07 ET | 1610 | 227.795 |
| 03:09 ET | 1900 | 228.325 |
| 03:12 ET | 2150 | 228.29 |
| 03:14 ET | 2147 | 228.2 |
| 03:16 ET | 539 | 228.205 |
| 03:18 ET | 1500 | 228.37 |
| 03:20 ET | 2435 | 228.19 |
| 03:21 ET | 439 | 228.27 |
| 03:23 ET | 2814 | 228.495 |
| 03:25 ET | 657 | 228.68 |
| 03:27 ET | 2808 | 228.67 |
| 03:30 ET | 3114 | 228.626 |
| 03:32 ET | 720 | 228.59 |
| 03:34 ET | 2310 | 228.935 |
| 03:36 ET | 3302 | 228.875 |
| 03:38 ET | 887 | 229 |
| 03:39 ET | 1300 | 228.985 |
| 03:41 ET | 8096 | 229.22 |
| 03:43 ET | 7934 | 229.2 |
| 03:45 ET | 1200 | 229.265 |
| 03:48 ET | 4500 | 229.26 |
| 03:50 ET | 5649 | 229.235 |
| 03:52 ET | 4500 | 229.29 |
| 03:54 ET | 14061 | 229.26 |
| 03:56 ET | 9204 | 228.715 |
| 03:57 ET | 11202 | 228.46 |
| 03:59 ET | 24506 | 228.72 |
Today
"LEQEMBI(R)" (Lecanemab) for the Treatment of Alzheimer's Disease Launched in China, from 16 minutes ago by Dow Jones
16 minutes ago by Dow Jones"LEQEMBI(R)" (Lecanemab) for the Treatment of Alzheimer's Disease Launched in China, from 16 minutes ago by Dow Jones
16 minutes ago by Dow JonesBiogen Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - BIIB, from 3 hours ago by Dow Jones
3 hours ago by Dow JonesDEADLINE ALERT for BIIB, DRCT, FSLY, CRGE: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders, from 3 hours ago by Dow Jones
3 hours ago by Dow JonesKessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action Lawsuit Against Biogen Inc. (BIIB), from 3 hours ago by Dow Jones
3 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biogen Inc | 32.5B | 28.6x | -18.14% |
ICON PLC | 26.1B | 38.0x | +4.68% |
Moderna Inc | 52.7B | -7.7x | --- |
IQVIA Holdings Inc | 38.5B | 29.0x | +46.62% |
Grifols SA | 5.9B | 21.0x | --- |
Biontech SE | 20.0B | 158.3x | --- |
Company Information
Biogen Inc. is a global biopharmaceutical company focused on discovering, developing, and delivering advanced therapies for people living with serious and complex diseases worldwide. It has a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). It is focused on advancing its pipeline in neurology, specialized immunology, and rare diseases. The Company’s marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; SKYCLARYS for the treatment of Friedreich's Ataxia; QALSODY for the treatment of ALS; and FUMADERM for the treatment of severe plaque psoriasis. It also has collaborations for the commercialization of LEQEMBI, ZURZUVAE, RITUXAN, RITUXAN HYCELA, GAZYVA, OCREVUS, LUNSUMIO, and COLUMVI. It commercializes a portfolio of biosimilars of advanced biologics including BENEPALI, IMRALDI, FLIXABI, and BYOOVIZ.
Contact Information
- Headquarters
- 225 Binney StreetCAMBRIDGE, MA, United States 02142
- Phone
- 781-464-2000
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Caroline Dorsa
- President, Chief Executive Officer, Director
- Christopher Viehbacher
- Chief Financial Officer, Executive Vice President
- Michael McDonnell
- Chief Human Resource Officer, Executive Vice President
- Ginger Gregory
- Executive Vice President, Chief Legal Officer
- Susan Alexander
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $32.5B |
|---|---|
Revenue (TTM) | $9.7B |
Shares Outstanding | 145.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.04 |
EPS | $8.00 |
Book Value | $102.14 |
P/E Ratio | 28.6x |
Price/Sales (TTM) | 3.4 |
Price/Cash Flow (TTM) | 19.1x |
Operating Margin | 17.21% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
